Chong B et al (2024) Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol

Kueh MTW et al (2024) The emergence of obesity in type 1 diabetes. Int J Obes (Lond) 48(3):289–301

Article  PubMed  Google Scholar 

Chew NWS et al (2022) Long-term prognosis of acute myocardial infarction associated with metabolic health and obesity status. Endocr Pract 28(8):802–810

Article  PubMed  Google Scholar 

Kong G et al (2023) A two-decade population-based study on the effect of hypertension in the general population with obesity in the United States. Obesity (Silver Spring) 31(3):832–840

Article  PubMed  Google Scholar 

Vernon ST et al (2021) Coronary artery disease burden in women poorly explained by traditional risk factors: sex disaggregated analyses from the BioHEART-CT study. Atherosclerosis 333:100–107

Article  CAS  PubMed  Google Scholar 

Weight N et al (2024) Impact of chronic kidney disease on the processes of care and long-term mortality of non-ST-segment-elevation myocardial infarction: a nationwide cohort study and long-term follow-up. J Am Heart Assoc 13(16):e032671

Article  PubMed  Google Scholar 

Weight N et al (2023) Temporal analysis of non-ST segment elevation-acute coronary syndrome (NSTEACS) outcomes in “young” patients under the age of fifty: a nationwide cohort study. Int J Cardiol 391:131294

Article  PubMed  Google Scholar 

Kong G et al (2024) The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: a propensity score-matched analysis. Diabetes Obes Metab 26(8):3328–3338

Article  CAS  PubMed  Google Scholar 

Figtree GA et al (2023) Clinical pathway for coronary atherosclerosis in patients without conventional modifiable risk factors: JACC state-of-the-art review. J Am Coll Cardiol 82(13):1343–1359

Article  PubMed  PubMed Central  Google Scholar 

Kong G et al (2023) Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients. Int J Cardiol 371:432–440

Article  PubMed  Google Scholar 

Kong G et al (2022) Prognostic Outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multiethnic study of 8680 Asian patients. Front Cardiovasc Med 9:869168

Article  PubMed  PubMed Central  Google Scholar 

Chew NWS et al (2022) Meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting for left main narrowing. Am J Cardiol 173:39–47

Article  PubMed  Google Scholar 

Chew NWS et al (2022) Coronary artery bypass grafting versus percutaneous coronary intervention for multivessel coronary artery disease: a one-stage meta-analysis. Front Cardiovasc Med 9:822228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong G et al (2023) Long-term prognosis of patients with coexisting obesity and malnutrition after acute myocardial infarction: a cohort study. Circ Cardiovasc Qual Outcomes 16(4):e009340

Article  PubMed  Google Scholar 

Kong G et al (2022) Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 Asian patients. J Thromb Thrombolysis 54(4):569–578

Article  PubMed  Google Scholar 

Yeong T et al (2022) Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis. ESC Heart Fail 9(2):1338–1350

Article  PubMed  PubMed Central  Google Scholar 

Anand VV et al (2023) Barriers and facilitators to engagement with a weight management intervention in Asian patients with overweight or obesity: a systematic review. Endocr Pract 29(5):398–407

Article  PubMed  Google Scholar 

Cenko E et al (2018) Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med 178(5):632–639

Article  PubMed  PubMed Central  Google Scholar 

Goh RSJ et al (2024) The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. Lancet Reg Health West Pac 49:101138

PubMed  PubMed Central  Google Scholar 

Chew NWS et al (2023) Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort. Lancet Reg Health Western Pac 37

Chong B et al (2023) The global syndemic of metabolic diseases in the young adult population: a consortium of trends and projections from the Global Burden of Disease 2000–2019. Metabolism 141:155402

Article  CAS  PubMed  Google Scholar 

Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906

Article  PubMed  Google Scholar 

Wan X et al (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135

Article  PubMed  PubMed Central  Google Scholar 

Figtree GA et al (2022) Mortality and cardiovascular outcomes in patients presenting with non-ST elevation myocardial infarction despite no standard modifiable risk factors: results from the SWEDEHEART registry. J Am Heart Assoc 11(15):e024818

Article  PubMed  PubMed Central  Google Scholar 

Figtree GA et al (2021) Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet 397(10279):1085–1094

Article  CAS  PubMed  Google Scholar 

González-Del-Hoyo M et al (2023) Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: insights from an international cohort of 23,489 patients with acute coronary syndrome. Am Heart J 264:20–30

Article  PubMed  Google Scholar 

Sheikhy A et al (2023) In-hospital and 1-year outcomes of patients without modifiable risk factors presenting with acute coronary syndrome undergoing PCI: a sex-stratified analysis. Front Cardiovasc Med 10

Guo W et al (2023) Characteristics, treatment, and mortality of patients hospitalized for first ST-segment elevation myocardial infarction without standard modifiable risk factors in China. RCM 24(9)

Justin Paul G et al (2023) Outcomes of ST segment elevation myocardial infarction without standard modifiable cardiovascular risk factors—newer insights from a prospective registry in India. Glob Heart 18(1):13

PubMed  PubMed Central  Google Scholar 

Jang SJ et al (2023) Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: age-stratified and sex-related analysis from nationwide readmissions database 2010–2014. Am J Prev Cardiol 14:100474

Article  PubMed  PubMed Central  Google Scholar 

Ball J et al ()2024 Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention. Open Heart 11(1)

Vernon ST et al (2019) ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes? J Am Heart Assoc 8(21):e013296

Article  PubMed  PubMed Central  Google Scholar 

Jain V et al (2023) Immune activation mediates the association of advanced hepatic fibrosis with adverse outcomes in patients with coronary artery disease. J Am Heart Assoc 12(24):e031230

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chew NWS et al (2022) FIB-4 predicts MACE and cardiovascular mortality in patients with nonalcoholic fatty liver disease. Can J Cardiol 38(11):1779–1780

Article  PubMed  Google Scholar 

Chew NWS et al (2024) Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population. Diabetes Res Clin Pract 211:111652

Article  CAS  PubMed  Google Scholar 

Lai AR et al (2023) Cardiovascular Outcomes in Acute Coronary Syndrome and Malnutrition: A Meta-Analysis of Nutritional Assessment Tools. JACC Adv 2(8):100635

Article  PubMed  PubMed Central  Google Scholar 

Vogel B et al (2021) The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 397(10292):2385–2438

Article  PubMed